Login
$RNTX
$0.38 -$0.02 (5.35%) After hours

$RNTX SEC Filings

Filed On Filing
16 Nov 2026 8-K: Other Events

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.

16 Nov 2026 10-Q
04 Sep 2026 8-K: Regulation FD Disclosure

Exhibit 99.1 Harnessing fibrosis, unleashing life Science Deck| September 2026 Copyright © 2026 Rein Therapeutics

27 Aug 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On August 21, 2026, Rein Therapeutics, Inc. (“Company”) received a notice of delisting (the “Notice”) from the Nasdaq Stock Market, LLC. The Notice stated that the Company had fallen below compliance with respect to the continued listing...

14 Aug 2026 SCHEDULE 13G
14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 10-Q
13 Aug 2026 SCHEDULE 13G/A
21 Jul 2026 8-K: Submission of Matters to a Vote of Security Holders

On July 20, 2026, Rein Therapeutics, Inc. held its 2026 Annual Meeting of Stockholders, for the purposes of:

14 Jul 2026 SCHEDULE 13G/A
08 Jun 2026 ARS
08 Jun 2026 DEFA14A
08 Jun 2026 Proxy statement: annual meeting on July 20, 2026

CEO pay $883K, down 50% · say-on-pay vote

28 May 2026 Form 4: Von Rickenbach Josef H, Director

Bought 3,420 shares ($3.56K) · Bought 15,950 shares ($16.7K) · Bought 23,190 shares ($24.5K) · 1 more

28 May 2026 PRE 14A
15 May 2026 10-Q
13 May 2026 Form 4: Windsor James Brian, Director

Bought 25,000 shares ($25K) · Disposed of 150,000 Stock Option (Right to Buy) (Grant/Award Acquisition)

08 May 2026 SCHEDULE 13G/A
08 May 2026 SCHEDULE 13G
07 May 2026 SCHEDULE 13G

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support